³Ô¹ÏÍøÕ¾

Latest drug development News | Page 6

CannaPacific and CSIRO trial novel encapsulation technologies for medicinal cannabinoids
Noxopharm completes $23m share placement
Novartis signs US$50 million commercial deal with Australian biotech firm
Weill Cornell entrepreneurship symposium touts innovation
Necrotising enterocolitis treatment closer
Baricitinib treatment linked to reduced mortality in COVID-19 patients
Sugar-coated viral proteins hijack and hitch a ride out of cells
New Hope for Alzheimer’s Disease
New understanding of how proteins operate
Midbrain organoids for automated chemical screening and disease research
Severe form of Inflammatory Bowel Disease linked to a strain of mouth bacteria
‘Genome Archeologists’ at University and UHN activate immune response against cancer
CAR NKT cells offer a promising novel immunotherapy for solid tumors
COVID-19 video update
Novel inflammation drug in development
Atlas Advisors Australia and Stoic Venture Capital celebrate Uniseed’s 20th anniversary
BioPharma News Wire: Agilex Biolabs Develops World’s Most Accurate Cannabinoid Assay
Funding boost for motor neurone disease research
UNSW academic awarded $1.5m grant for treatment of malignant melanoma
How Australia can better avoid future medical supply crises
New screening technology works to better predict drug’s shelf life and stability
New tool allows researchers to predict key functional sites in proteins
Tiny Protein Packages Released from Cells May Serve as Biomarkers for Early Blood-Based Cancer Diagnosis
Malaria discovery could expedite antiviral treatment for COVID
Engineers enlist fungi to advance against disease
Partnership to develop head and neck cancer vaccine
Researchers Identify MicroRNA That Shows Promise for Hair Regrowth
How AI is enabling COVID-19 research
Molecular Horizons and IHMRI ARC funding success
Chemical approach created to discover compounds for drug development
One million epilepsy patients in China missing out on beneficial surgery
Location, location, location – even gut immune response is site-specific
Drug trial into treatment of COVID-19 expanded to national level
Southampton joins new initiative to rapidly identify treatment for COVID-19
$200,000 funding boost strengthens Australian-German alliance iCAIR fight against COVID-19
Adaptive Biotechnologies and Microsoft launch groundbreaking ImmuneCODE database to share populationwide immune response to COVID-19 virus
Rheumatoid arthritis drug shows promise against COVID-19, study finds
QIMR Berghofer researcher recognised with Queen’s Birthday honour
Queensland acoustic compound support could help COVID-19 breakthroughs
Monash University and oNKo-innate Announce Research Partnership
Record number of countries contribute data revealing disturbing rates of antimicrobial resistance
A small twist leads to a big reaction
University led COVID19 drug trial expands into home testing
Victoria leading way on COVID-19 research
Manufacturing toolbox for porous silica is good news for production of medicine
Adaptive Biotechnologies and Microsoft launch virtual ImmuneRACE study to inform novel COVID-19 diagnostics
Southampton to play leading role in fast-tracked COVID-19 treatment trial
New Macrolactone Database Could Aid Drug Discovery, Research